ATOM vs. PFE

In the year-to-date period, ATOM achieves a -44.48% return, which is significantly lower than PFE's -13.00% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Atomera Incorporated (ATOM) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ATOM Sharpe Ratio is 0.44, which is higher than the PFE Sharpe Ratio of -0.66. The chart below compares the historical Sharpe Ratios of ATOM and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

ATOM has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 7.63%.

The maximum ATOM drawdown since its inception was -94.73%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for ATOM and PFE. For additional features, visit the drawdowns tool.

This section allows you to compare key financial metrics between Atomera Incorporated and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.